OLD National Bancorp IN Acquires 7,326 Shares of Roche Holding AG $RHHBY

OLD National Bancorp IN boosted its holdings in shares of Roche Holding AG (OTCMKTS:RHHBY) by 2.9% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 261,317 shares of the company’s stock after purchasing an additional 7,326 shares during the period. OLD National Bancorp IN’s holdings in Roche were worth $10,604,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Rhumbline Advisers lifted its stake in Roche by 7.4% during the first quarter. Rhumbline Advisers now owns 107,252 shares of the company’s stock worth $4,413,000 after purchasing an additional 7,374 shares during the last quarter. Altrius Capital Management Inc increased its holdings in shares of Roche by 3.6% during the first quarter. Altrius Capital Management Inc now owns 189,993 shares of the company’s stock worth $7,818,000 after buying an additional 6,545 shares in the last quarter. Everett Harris & Co. CA acquired a new position in shares of Roche during the first quarter worth $445,000. Bard Financial Services Inc. increased its holdings in shares of Roche by 25.3% during the first quarter. Bard Financial Services Inc. now owns 138,900 shares of the company’s stock worth $5,716,000 after buying an additional 28,050 shares in the last quarter. Finally, Riverbridge Partners LLC increased its holdings in shares of Roche by 6.7% during the first quarter. Riverbridge Partners LLC now owns 37,826 shares of the company’s stock worth $1,557,000 after buying an additional 2,381 shares in the last quarter.

Roche Trading Up 1.3%

Shares of Roche stock opened at $45.30 on Friday. The business has a 50-day moving average price of $40.76 and a two-hundred day moving average price of $40.25. Roche Holding AG has a 1-year low of $34.10 and a 1-year high of $45.46.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on RHHBY. Hsbc Global Res upgraded shares of Roche from a “hold” rating to a “strong-buy” rating in a report on Thursday. HSBC upgraded shares of Roche from a “hold” rating to a “buy” rating and set a $50.00 price target for the company in a report on Thursday. Three investment analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $50.00.

Roche Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.